Life Sciences Academy | Navigating US Bio-security Rules: Biosecure Act and Its Impact on Global Biotech/Pharma

US biosecurity policy is rapidly evolving. The proposed Biosecure Act and related regulations, are poised to reshape how biotech and pharma companies source, partner, and invest across borders. This webinar breaks down what’s changing, who is affected, and what EU/UK companies with US touchpoints should be doing now.

We will cover:

1. Expected timelines, scope, and obligations under the Biosecure Act
2. How other related regulations impact supply chains, research collaborations (including university/CRO arrangements), and capital flows
3. Practical steps to prepare—counterparty screening, contractual protections, JV/transaction structuring, and governance

We’ll leave time for Q&A to help you translate policy awareness into concrete action.